Education
About Us
Working with TipRanks
Follow Us
PharmaNutra SpA (IT:PHN)
:PHN
Total Valuation
PharmaNutra SpA has a market cap or net worth of €469.53M. The enterprise value is €459.32M.
Market Cap€469.53M
Enterprise Value€459.32M
Share Statistics
PharmaNutra SpA has 9,680,977 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding9,680,977
Owned by Insiders34.54%
Owned by Institutions―
Financial Efficiency
PharmaNutra SpA’s return on equity (ROE) is 0.27 and return on invested capital (ROIC) is 17.58%.
Return on Equity (ROE)0.27
Return on Assets (ROA)0.14
Return on Invested Capital (ROIC)17.58%
Return on Capital Employed (ROCE)0.30
Revenue Per Employee984.31K
Profits Per Employee140.27K
Employee Count118
Asset Turnover0.99
Inventory Turnover4.90
Valuation Ratios
The current PE Ratio of PharmaNutra SpA is 27.6. PharmaNutra SpA’s PEG ratio is 1.05.
PE Ratio27.6
PS Ratio4.48
PB Ratio8.41
Price to Fair Value8.41
Price to FCF32.17
Price to Operating Cash Flow18.37
PEG Ratio1.05
Income Statement
In the last 12 months, PharmaNutra SpA had revenue of 116.15M and earned 16.61M in profits. Earnings per share was 1.73.
Revenue116.15M
Gross Profit82.79M
Operating Income27.37M
Pretax Income27.16M
Net Income16.61M
EBITDA32.01M
Earnings Per Share (EPS)1.73
Cash Flow
In the last 12 months, operating cash flow was 12.32M and capital expenditures -4.12M, giving a free cash flow of 8.21M billion.
Operating Cash Flow12.32M
Free Cash Flow8.21M
Free Cash Flow per Share0.85
Dividends & Yields
PharmaNutra SpA pays an annual dividend of €1, resulting in a dividend yield of 2.04%
Dividend Per Share€1
Dividend Yield2.04%
Payout Ratio57.47%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.45
52-Week Price Change-12.84%
50-Day Moving Average45.72
200-Day Moving Average48.86
Relative Strength Index (RSI)62.85
Average Volume (3m)38.09K
Important Dates
PharmaNutra SpA upcoming earnings date is Nov 10, 2025, TBA (Confirmed).
Last Earnings DateSep 8, 2025
Next Earnings DateNov 10, 2025
Ex-Dividend DateMay 05, 2025
Financial Position
PharmaNutra SpA as a current ratio of 2.38, with Debt / Equity ratio of 37.32%
Current Ratio2.38
Quick Ratio2.12
Debt to Market Cap0.04
Net Debt to EBITDA0.27
Interest Coverage Ratio15.94
Taxes
In the past 12 months, PharmaNutra SpA has paid 10.61M in taxes.
Income Tax10.61M
Effective Tax Rate0.39
Enterprise Valuation
PharmaNutra SpA EV to EBITDA ratio is 16.60, with an EV/FCF ratio of 32.70.
EV to Sales4.55
EV to EBITDA16.60
EV to Free Cash Flow32.70
EV to Operating Cash Flow25.92
Balance Sheet
PharmaNutra SpA has €15.68M in cash and marketable securities with €22.13M in debt, giving a net cash position of -€6.45M billion.
Cash & Marketable Securities€15.68M
Total Debt€22.13M
Net Cash-€6.45M
Net Cash Per Share-€0.67
Tangible Book Value Per Share€4.05
Margins
Gross margin is 66.81%, with operating margin of 23.44%, and net profit margin of 14.22%.
Gross Margin66.81%
Operating Margin23.44%
Pretax Margin23.26%
Net Profit Margin14.22%
EBITDA Margin27.41%
EBIT Margin24.17%
Analyst Forecast
The average price target for PharmaNutra SpA is €81.00, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target€81.00
Price Target Upside65.47% Upside
Analyst ConsensusStrong Buy
Analyst Count3
Revenue Growth Forecast13.75%
EPS Growth Forecast16.66%